Treatment

Venetoclax, MITOXANTRONE , CYTARABINE , Venetoclax, Venetoclax clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- Other
Phase-I/II trial for relapsed or refractory AML patients combining cytarabine and mitoxantrone with venetoclax (TUD-RELAX1-070)
This study is for adults with a type of blood cancer called AML that has come back or not responded to usual treatments. It's testing a new combination of medicines to see if it's safe and helps more people. It combines standard chemotherapy drugs with a newer drug called venetoclax.
For: female and male adult patients with acute myeloid leukemia (AML) at first or second relapse after · intensive chemotherapy including allogeneic stem cell transplantation or primary · refractory to standard induction chemotherapy who are eligible for intensive
Germany